Nuon뉴온

Nuon's shares have fallen about 86% over the past year, and the filings show large losses despite strong revenue growth in 2025.

Nuon sells health functional foods and household goods, mostly through online marketplaces, and works with outsourced manufacturers. Trailing twelve-month revenue is about ₩52.4B, but operating and net losses are large, at about ₩-6.0B and ₩-48.9B. The share price closed at ₩1,574 on 2026-10-26, with a market cap of about ₩24.5B.

What stands out

• Revenue rose 184.2% in 2025 to about ₩48.2B, but the operating loss widened to about ₩-13.4B, an operating margin of -27.8%.
• Trailing twelve-month net loss is about ₩-48.9B against revenue of about ₩52.4B, a net margin of -93.3%.
• Cash is about ₩5.3B against borrowings of about ₩0.7B, and free cash flow over the trailing period was about ₩-9.2B.
• Price-to-book is 0.3 and price-to-sales is 0.5, but P/E is not meaningful because earnings are negative and no dividend is paid.
• Filings in July 2026 include a rights offering decision, a third-party allotment, and equity-linked bond acquisitions, which point to ongoing fundraising.
• Foreign ownership fell from 0.5% to 0.4% over 60 days, and the 20-day flow data shows foreign net selling.

What to watch

• The next results and filings, including the full-year 2026 report, which were not in the data.
• Progress and dilution effects of the rights offering and equity-linked bonds, and whether cash needs are met.
• No recent news headlines were provided, so no company-specific news could be assessed.